Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly.

Marques-Pamies, Montserrat; Gil, Joan; Jordà, Mireia; Puig-Domingo, Manel

Marques-Pamies, Montserrat; Gil, Joan; Jordà, Mireia; Puig-Domingo, Manel.

Afiliação

Marques-Pamies M; Department of Endocrinology, Hospital Municipal de Badalona, Badalona, Catalonia, Spain.
Gil J; Endocrine Research Unit, Germans Trias i Pujol Research Institute, Badalona, Spain; Network Research Center for Rare Diseases, CIBERER, Unit 747, Instituto de Salud Carlos III, Madrid, Spain; Department of Endocrinology, Research Center for Pituitary Diseases, Hospital Sant Pau, IIB-SPau, Barcelona,
Jordà M; Endocrine Research Unit, Germans Trias i Pujol Research Institute, Badalona, Spain.
Puig-Domingo M; Endocrine Research Unit, Germans Trias i Pujol Research Institute, Badalona, Spain; Network Research Center for Rare Diseases, CIBERER, Unit 747, Instituto de Salud Carlos III, Madrid, Spain; Department of Endocrinology and Nutrition, Germans Trias i Pujol University Hospital, Badalona, Spain; Depar

Arch Med Res ; 54(8): 102924, 2023 12.

Article em En | MEDLINE | ID: mdl-38042683

Assuntos

Acromegalia; Humanos; Acromegalia/tratamento farmacológico; Acromegalia/metabolismo; Somatostatina/uso terapêutico; Receptores de Somatostatina/metabolismo; Receptores de Somatostatina/uso terapêutico; Estudos Retrospectivos; Inteligência Artificial; Resultado do Tratamento

Palavras-chave

Acromegaly; Artificial intelligence; First-generation somatostatin analogs; Personalized treatment; Precision; Prediction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acromegalia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acromegalia Idioma: En Ano de publicação: 2023 Tipo de documento: Article